Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis-Reference-Cited by-同舟云学术

Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis

Published:2022-02-17 Issue:2 Volume:9 Page:925-941
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Pappritz Kathleen¹²³,Lin Jie²,El‐Shafeey Muhammad¹²³⁴⁵,Fechner Henry⁶,Kühl Uwe⁷,Alogna Alessio⁷,Spillmann Frank⁷,Elsanhoury Ahmed¹²³,Schulz Rainer⁴,Tschöpe Carsten¹²³⁷,Van Linthout Sophie¹²³

Affiliation:

1. BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité Universitätmedizin Berlin Berlin Germany

2. Berlin‐Brandenburg Center for Regenerative Therapies Charité‐Universitätsmedizin Berlin, Campus Virchow Klinikum (CVK) Berlin Germany

3. German Center for Cardiovascular Research (DZHK), Partner site Berlin Berlin Germany

4. Physiologisches Institut Fachbereich Medizin der Justus‐Liebig‐Universität Giessen Germany

5. Medical Biotechnology Research Department Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications Alexandria Egypt

6. Department of Applied Biochemistry, Institute for Biotechnology Technische Universität Berlin Berlin Germany

7. Department of Cardiology Charité – Universitätsmedizin Berlin, CVK Berlin Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13845

Reference48 articles.

1. Management of Myocarditis-Related Cardiomyopathy in Adults

2. SARS‐CoV‐2 ‐related myocarditis‐like syndromes S hakespeare's question: what's in a name?

3. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions